Windtree Therapeutics (WINT) Short Interest Ratio & Short Volume $1.14 +0.01 (+0.88%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.16 +0.02 (+1.75%) As of 04/17/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Windtree Therapeutics Short Interest DataWindtree Therapeutics (WINT) has a short interest of 279,300 shares, representing 37.32% of the float (the number of shares available for trading by the public). This marks a 466.53% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 733,823 shares to cover all short positions.Current Short Interest279,300 sharesPrevious Short Interest49,300 sharesChange Vs. Previous Month+466.53%Dollar Volume Sold Short$351,918.00Short Interest Ratio0.1 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares749,000 sharesFloat Size748,400 sharesShort Percent of Float37.32%Today's Trading Volume64,642 sharesAverage Trading Volume733,823 sharesToday's Volume Vs. Average9% Short Selling Windtree Therapeutics? Sign up to receive the latest short interest report for Windtree Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartWINT Short Interest Over TimeWINT Days to Cover Over TimeWINT Percentage of Float Shorted Over Time Windtree Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025279,300 shares $351,918.00 +466.5%37.3%0.1 $1.26 3/15/202549,300 shares $101,065.00 -40.6%6.6%0 $2.05 2/28/202583,000 shares $263,940.00 +44.9%11.1%0.3 $3.18 2/15/202557,300 shares $393,651.00 -67.1%7.7%0.4 $6.87 1/31/2025174,100 shares $22,737.46 -80.9%1.6%0 $0.13 1/15/2025909,000 shares $220,887.00 +72.4%8.3%0.3 $0.24 12/31/2024527,200 shares $184,150.96 +6.1%5.9%0.2 $0.35 12/15/2024497,000 shares $175,639.80 +228.5%5.6%0.3 $0.35 11/30/2024151,300 shares $80,264.65 +389.6%1.7%0.1 $0.53 11/15/202430,900 shares $14,680.59 -84.2%0.4%0 $0.48 Get the Latest News and Ratings for WINT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Windtree Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/2024195,700 shares $137,655.38 +301.9%2.4%0.1 $0.70 10/15/202448,700 shares $32,142.00 -50.7%1.4%0 $0.66 9/30/202498,700 shares $235,893.00 +174.9%2.8%0.1 $2.39 9/15/202435,900 shares $113,803.00 -65.9%2.6%0 $3.17 8/31/2024105,400 shares $854,794.00 -6.8%23.9%0.1 $8.11 8/15/2024113,100 shares $1.26 million -56.8%25.6%0.1 $11.14 7/31/2024261,700 shares $2.39 million +455.6%59.3%0.3 $9.12 7/15/202447,100 shares $174,270.00 -17.5%10.7%1.5 $3.70 6/30/202457,100 shares $183,291.00 +21.2%12.9%1.8 $3.21 6/15/202447,100 shares $146,010.00 +20.8%10.7%1.7 $3.10 5/31/202439,000 shares $138,060.00 +89.3%9.1%1.6 $3.54 5/15/202420,600 shares $94,784.72 +62.2%4.8%0.8 $4.60 4/30/202412,700 shares $63,881.00 +388.5%3.0%0.6 $5.03 4/15/20242,600 shares $19,656.00 -93.5%N/A0.2 $7.56 3/31/202439,700 shares $14,053.80 +30.2%0.5%0.2 $0.35 3/15/202430,500 shares $10,370.00 -47.8%0.4%0.1 $0.34 2/29/202458,400 shares $21,024.00 -42.2%0.8%0.2 $0.36 2/15/2024101,100 shares $36,092.70 -56.0%1.9%0.3 $0.36 1/31/2024229,600 shares $96,500.88 +353.8%5.3%0.8 $0.42 1/15/202450,600 shares $28,953.32 +25.6%1.0%0.2 $0.57 12/31/202340,300 shares $28,975.70 +108.8%N/A0.3 $0.72 12/15/202319,300 shares $14,089.00 -55.5%0.5%0.2 $0.73 11/30/202343,400 shares $50,344.00 -13.4%1.1%0.4 $1.16 11/15/202350,100 shares $46,081.98 -22.5%1.2%0.5 $0.92 10/31/202364,600 shares $67,830.00 -65.8%1.5%0.5 $1.05 10/15/2023188,900 shares $236,125.00 +540.3%4.3%1.5 $1.25 9/30/202329,500 shares $27,983.70 +81.0%0.7%0.2 $0.95 9/15/202316,300 shares $18,745.00 +27.3%0.4%0.1 $1.15 8/31/202312,800 shares $14,095.36 -75.8%2.0%0.1 $1.10 8/15/202352,800 shares $85,536.00 +294.0%7.9%0.2 $1.62Trump’s Secret Weapon (Ad)Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.Get Your FREE Presidential Transition Guide Today 7/31/202313,400 shares $18,626.00 +162.8%2.0%0 $1.39 7/15/20235,100 shares $6,834.00 -42.1%N/A0 $1.34 6/30/20238,800 shares $11,000.00 -90.5%N/A0 $1.25 6/15/202392,500 shares $142,450.00 -2.9%N/A0.1 $1.54 5/31/202395,300 shares $121,984.00 -51.2%N/A0.1 $1.28 5/15/2023195,100 shares $290,699.00 +64.4%N/A0.2 $1.49 4/30/2023118,700 shares $194,668.00 +136.9%68.7%0.1 $1.64 4/15/202350,100 shares $219,438.00 +87.6%8.5%0.1 $4.38 3/31/202326,700 shares $133,233.00 -2.9%4.7%0.2 $4.99 3/15/202327,500 shares $132,550.00 -53.0%4.9%0.3 $4.82 2/28/202358,500 shares $367,380.00 +604.8%10.3%0.6 $6.28 2/15/20238,300 shares $1,232.55 -98.9%N/A0.1 $0.15 1/31/2023754,800 shares $120,768.00 +16.1%N/A1.4 $0.16 1/15/2023650,300 shares $143,033.49 -28.2%N/A1.3 $0.22 12/30/2022905,900 shares $154,003.00 -28.7%N/A2 $0.17 12/15/20221,270,000 shares $226,060.00 +4.1%N/A1.4 $0.18 11/30/20221,220,000 shares $234,850.00 -3.2%N/A1.3 $0.19 11/15/20221,260,000 shares $110,250.00 -9.4%5.3%1.2 $0.09 10/31/20221,390,000 shares $238,385.00 -10.9%7.4%0.7 $0.17 10/15/20221,560,000 shares $379,704.00 +26.8%8.3%0.8 $0.24 9/30/20221,230,000 shares $369,123.00 +44.6%6.5%0.7 $0.30 9/15/2022850,900 shares $314,662.82 -8.3%4.5%0.6 $0.37 8/31/2022928,000 shares $365,632.00 +21.9%5.1%0.7 $0.39 8/15/2022761,500 shares $288,608.50 +0.0%4.2%0.6 $0.38 7/31/2022761,200 shares $299,913.56 -19.9%4.3%3.1 $0.39 7/15/2022950,700 shares $384,558.15 +6.8%5.4%3.4 $0.40 6/30/2022890,200 shares $371,213.40 +3.6%5.1%1.1 $0.42 6/15/2022858,900 shares $365,032.50 -7.5%4.9%1.1 $0.43 5/31/2022928,500 shares $452,179.50 +18.9%5.4%1.2 $0.49 5/15/2022781,200 shares $429,660.00 -12.1%4.5%1.1 $0.55 4/30/2022888,700 shares $657,282.52 +104.6%5.3%1.3 $0.74 4/15/2022434,400 shares $462,679.44 -0.5%2.6%0.6 $1.07 3/31/2022436,400 shares $497,496.00 -9.1%2.6%3.9 $1.14 3/15/2022480,100 shares $458,495.50 +10.4%2.9%3.4 $0.96 2/28/2022434,800 shares $465,236.00 -21.0%2.6%3.1 $1.07 2/15/2022550,600 shares $578,130.00 +60.9%3.3%3.4 $1.05 1/31/2022342,200 shares $386,686.00 -30.6%2.0%1.9 $1.13 1/15/2022493,000 shares $734,570.00 +3.1%2.9%2.5 $1.49 12/31/2021478,000 shares $769,580.00 -19.7%2.8%1.8 $1.61 12/15/2021595,400 shares $940,732.00 -12.9%3.5%1.7 $1.58 11/30/2021683,600 shares $1.17 million -5.3%4.2%2 $1.71 11/15/2021721,900 shares $1.24 million -15.1%4.5%2 $1.72 10/29/2021849,800 shares $1.51 million -21.3%5.6%2.2 $1.78 10/15/20211,080,000 shares $2.46 million +6.9%6.9%1.6 $2.28 9/30/20211,010,000 shares $2.08 million -18.6%6.5%1.6 $2.06 9/15/20211,240,000 shares $2.26 million -0.8%8.0%2.1 $1.82 8/31/20211,250,000 shares $2.45 million -27.3%8.1%1.8 $1.96 8/13/20211,720,000 shares $3.13 million +10.3%11.2%0.6 $1.82 7/30/20211,560,000 shares $2.95 million +1.3%19.8%0.5 $1.89 7/15/20211,540,000 shares $2.82 million -1.9%19.5%0.5 $1.83Trump’s Secret Weapon (Ad)Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.Get Your FREE Presidential Transition Guide Today 6/30/20211,570,000 shares $3.60 million +6.1%19.9%0.5 $2.29 6/15/20211,480,000 shares $3.37 million +108.2%18.8%0.5 $2.28 5/28/2021710,900 shares $1.26 million +10.8%9.0%0.2 $1.77 5/14/2021641,500 shares $1.08 million +95.6%8.1%0.9 $1.68 4/30/2021328,000 shares $734,720.00 +35.9%4.7%0.7 $2.24 4/15/2021241,400 shares $555,220.00 +87.1%3.5%0.6 $2.30 3/31/2021129,000 shares $276,060.00 -18.2%3.9%0.4 $2.14 3/15/2021157,600 shares $660,344.00 +81.4%4.6%1 $4.19 2/26/202186,900 shares $438,410.50 +1.6%2.5%1.8 $5.05 2/12/202185,500 shares $469,395.00 -3.9%2.5%3.6 $5.49 1/29/202189,000 shares $501,070.00 -0.8%2.6%5 $5.63 1/15/202189,700 shares $554,346.00 No Change2.6%6.5 $6.18 WINT Short Interest - Frequently Asked Questions What is Windtree Therapeutics' current short interest? Short interest is the volume of Windtree Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 279,300 shares of WINT short. 37.32% of Windtree Therapeutics' shares are currently sold short. Learn More on Windtree Therapeutics' current short interest. What is a good short interest percentage for Windtree Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 37.32% of Windtree Therapeutics' floating shares are currently sold short. Is Windtree Therapeutics' short interest increasing or decreasing? Windtree Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 279,300 shares, an increase of 466.5% from the previous total of 49,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Windtree Therapeutics' float size? Windtree Therapeutics currently has issued a total of 749,000 shares. Some of Windtree Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Windtree Therapeutics currently has a public float of 748,400 shares. How does Windtree Therapeutics' short interest compare to its competitors? 37.32% of Windtree Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Windtree Therapeutics: Alaunos Therapeutics, Inc. (3.33%), Kazia Therapeutics Limited (1.63%), Sonoma Pharmaceuticals, Inc. (3.94%), Clearmind Medicine Inc. (6.19%), CNS Pharmaceuticals, Inc. (11.60%), Lixte Biotechnology Holdings, Inc. (1.60%), Creative Medical Technology Holdings, Inc. (2.60%), Upexi, Inc. (2.70%), Jaguar Health, Inc. (9.15%), Titan Pharmaceuticals, Inc. (1.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Windtree Therapeutics stock? Short selling WINT is an investing strategy that aims to generate trading profit from Windtree Therapeutics as its price is falling. WINT shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Windtree Therapeutics? A short squeeze for Windtree Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WINT, which in turn drives the price of the stock up even further. How often is Windtree Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WINT, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies TCRT Short Interest KZIA Short Interest SNOA Short Interest CMND Short Interest CNSP Short Interest LIXT Short Interest CELZ Short Interest UPXI Short Interest JAGX Short Interest TTNP Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:WINT) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WINT Stock Free WINT Stock Alerts